Department of Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
3rd Department of Internal Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria.
Int J Cardiol. 2014 Jun 1;174(1):90-5. doi: 10.1016/j.ijcard.2014.03.149. Epub 2014 Mar 28.
The Occluded Artery Trial (OAT) randomized stable patients (n=2201)>24 h (calendar days 3-28) after myocardial infarction (MI) with totally occluded infarct-related arteries (IRA), to percutaneous coronary intervention (PCI) with optimal medical therapy, or optimal medical therapy alone (MED). PCI had no impact on the composite of death, reinfarction, or class IV heart failure over extended follow-up of up to 9 years. We evaluated the impact of early and late reinfarction and definition of MI on subsequent mortality.
Reinfarction was adjudicated according to an adaptation of the 2007 universal definition of MI and the OAT definition (≥2 of the following--symptoms, EKG and biomarkers). Cox regression models were used to analyze the effect of post-randomization reinfarction and baseline variables on time to death. After adjustment for baseline characteristics the 169 (PCI: n=95; MED: n=74) patients who developed reinfarction by the universal definition had a 4.15-fold (95% CI 3.03-5.69, p<0.001) increased risk of death compared to patients without reinfarction. This risk was similar for both treatment groups (interaction p=0.26) and when MI was defined by the stricter OAT criteria. Reinfarctions occurring within 6 months of randomization had similar impact on mortality as reinfarctions occurring later, and the impact of reinfarction due to the same IRA and a different epicardial vessel was similar.
For stable post-MI patients with totally occluded infarct arteries, reinfarction significantly independently increased the risk of death regardless of the initial management strategy (PCI vs. MED), reinfarction definition, location and early or late occurrence.
闭塞动脉试验(OAT)将 24 小时(日历天 3-28)后发生完全闭塞性梗死相关动脉(IRA)的稳定型心肌梗死(MI)患者(n=2201)随机分为接受经皮冠状动脉介入治疗(PCI)联合最佳药物治疗与单纯最佳药物治疗(MED)。在长达 9 年的扩展随访中,PCI 并未对死亡、再梗死或 IV 级心力衰竭的复合终点产生影响。我们评估了早期和晚期再梗死以及 MI 的定义对随后死亡率的影响。
再梗死的判定依据是对 2007 年 MI 的通用定义和 OAT 定义(≥以下 2 项-症状、心电图和生物标志物)的改编。采用 Cox 回归模型分析了随机分组后再梗死和基线变量对死亡时间的影响。在校正基线特征后,根据通用定义发生再梗死的 169 例(PCI:n=95;MED:n=74)患者的死亡风险比未发生再梗死的患者增加了 4.15 倍(95%CI 3.03-5.69,p<0.001)。两组治疗组(交互作用 p=0.26)和使用更严格的 OAT 标准定义 MI 时,这种风险相似。随机分组后 6 个月内发生的再梗死对死亡率的影响与晚期再梗死相似,同一 IRA 和不同心外膜血管引起的再梗死的影响也相似。
对于完全闭塞性 IRA 的稳定型 MI 后患者,再梗死显著增加了死亡率,无论初始治疗策略(PCI 与 MED)、再梗死定义、位置以及早期或晚期发生,再梗死均独立增加了死亡率。